1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Muranyi, A. Finn, B.E. Gippert, G.P. Forsen, S. Stenflo, J. Drakenberg, T. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 1 90.00 90.00 90.00 1.000 1.000 1.000 C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking US Biochemistry BICHAW 0033 0006-2960 37 10605 10615 10.1021/bi980522f 9692950 Solution structure of the N-terminal EGF-like domain from human factor VII. 1998 UK Nature NATUAS 0006 0028-0836 380 41 The Crystal Structure of the Complex of Blood Coagulation Factor Viia with Soluble Tissue Factor 1996 US Protein Sci. PRCIEI 0795 0961-8368 1 81 The Three-Dimensional Structure of the First Egf-Like Module of Human Factor Ix: Comparison with Egf and Tgf-Alpha 1992 US Biochemistry BICHAW 0033 0006-2960 31 5974 Three-Dimensional Structure of the Apo Form of the N-Terminal Egf-Like Module of Blood Coagulation Factor X as Determined by NMR Spectroscopy and Simulated Folding 1992 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 4432.865 FACTOR VII 3.4.21.21 N-TERMINAL EGF-LIKE DOMAIN 1 man polymer no no SDGDQCASSPCQNGGSCKDQLQSYICFCLPAFEGRNCETHK SDGDQCASSPCQNGGSCKDQLQSYICFCLPAFEGRNCETHK A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n human Homo sample 9606 BLOOD Homo sapiens pdbx_database_status pdbx_struct_assembly pdbx_struct_oper_list struct_conf struct_conf_type repository Initial release Version format compliance Version format compliance Derived calculations Other 1 0 1999-02-16 1 1 2008-03-24 1 2 2011-07-13 1 3 2017-11-29 _pdbx_database_status.process_site Y BNL 1998-05-28 REL REL NO DISTANCE RESTRAINT VIOLATED BY MORE THAN 0.2 ANGSTROM AND NO DIHEDRAL ANGLE RESTRAINTS VIOLATED BY MORE THAN 2 DEGREES 100 23 COSY 2Q TOCSY NOESY NO SALT ADDED 5.6 1 atm 298 K DISTANCE GEOMETRY EMBEDDING WITHOUT METRIZATION FOLLOWED BY RESTRAINED SIMULATED ANNEALING AND SIMULATED ANNEALING REFINEMENT H2O AND D2O BRUNGER refinement X-PLOR 3.1 structure solution X-PLOR 500 GE OMEGA 600 Varian UNITYPLUS SER 45 n 1 SER 45 A ASP 46 n 2 ASP 46 A GLY 47 n 3 GLY 47 A ASP 48 n 4 ASP 48 A GLN 49 n 5 GLN 49 A CYS 50 n 6 CYS 50 A ALA 51 n 7 ALA 51 A SER 52 n 8 SER 52 A SER 53 n 9 SER 53 A PRO 54 n 10 PRO 54 A CYS 55 n 11 CYS 55 A GLN 56 n 12 GLN 56 A ASN 57 n 13 ASN 57 A GLY 58 n 14 GLY 58 A GLY 59 n 15 GLY 59 A SER 60 n 16 SER 60 A CYS 61 n 17 CYS 61 A LYS 62 n 18 LYS 62 A ASP 63 n 19 ASP 63 A GLN 64 n 20 GLN 64 A LEU 65 n 21 LEU 65 A GLN 66 n 22 GLN 66 A SER 67 n 23 SER 67 A TYR 68 n 24 TYR 68 A ILE 69 n 25 ILE 69 A CYS 70 n 26 CYS 70 A PHE 71 n 27 PHE 71 A CYS 72 n 28 CYS 72 A LEU 73 n 29 LEU 73 A PRO 74 n 30 PRO 74 A ALA 75 n 31 ALA 75 A PHE 76 n 32 PHE 76 A GLU 77 n 33 GLU 77 A GLY 78 n 34 GLY 78 A ARG 79 n 35 ARG 79 A ASN 80 n 36 ASN 80 A CYS 81 n 37 CYS 81 A GLU 82 n 38 GLU 82 A THR 83 n 39 THR 83 A HIS 84 n 40 HIS 84 A LYS 85 n 41 LYS 85 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 identity operation 0.0000000000 0.0000000000 0.0000000000 1 A ARG 79 0.245 SIDE CHAIN 2 A ARG 79 0.296 SIDE CHAIN 3 A ARG 79 0.309 SIDE CHAIN 4 A ARG 79 0.200 SIDE CHAIN 5 A ARG 79 0.252 SIDE CHAIN 6 A ARG 79 0.180 SIDE CHAIN 7 A ARG 79 0.231 SIDE CHAIN 8 A ARG 79 0.307 SIDE CHAIN 9 A ARG 79 0.183 SIDE CHAIN 10 A ARG 79 0.282 SIDE CHAIN 11 A ARG 79 0.293 SIDE CHAIN 12 A ARG 79 0.304 SIDE CHAIN 13 A ARG 79 0.158 SIDE CHAIN 14 A ARG 79 0.246 SIDE CHAIN 15 A ARG 79 0.317 SIDE CHAIN 16 A ARG 79 0.129 SIDE CHAIN 17 A ARG 79 0.287 SIDE CHAIN 18 A ARG 79 0.317 SIDE CHAIN 19 A ARG 79 0.291 SIDE CHAIN 20 A ARG 79 0.266 SIDE CHAIN 21 A ARG 79 0.282 SIDE CHAIN 22 A ARG 79 0.089 SIDE CHAIN 23 A ARG 79 0.307 SIDE CHAIN 1 A ASP 46 61.74 109.49 1 A CYS 50 -83.55 43.70 1 A SER 53 50.91 70.49 1 A GLN 64 -103.79 -165.64 1 A SER 67 179.36 -112.44 1 A CYS 72 -58.41 179.43 1 A THR 83 -104.24 76.71 2 A ASP 48 -60.91 -89.63 2 A GLN 49 -129.15 -58.73 2 A LEU 65 -51.02 -82.03 2 A GLN 66 -36.18 -31.42 2 A SER 67 169.91 -153.43 2 A CYS 72 41.13 -159.53 3 A GLN 49 40.53 -83.13 3 A CYS 50 -80.79 43.23 3 A SER 53 67.74 86.30 3 A CYS 55 -42.45 151.69 3 A SER 67 179.63 -134.90 3 A CYS 72 -105.43 -160.53 3 A GLU 77 -170.21 114.82 3 A ASN 80 -152.20 19.54 3 A THR 83 -118.04 75.82 4 A ASP 48 -175.07 -83.64 4 A SER 53 67.52 76.93 4 A SER 67 -178.96 -131.13 4 A CYS 72 -74.92 -159.27 4 A ASN 80 -152.71 27.75 4 A THR 83 -111.92 67.67 5 A ASP 46 -179.37 -100.75 5 A ASP 48 -176.50 -82.82 5 A SER 52 -149.50 18.93 5 A SER 53 54.29 72.60 5 A SER 67 179.04 -123.59 5 A CYS 72 -59.25 177.82 5 A GLU 77 -167.22 113.82 5 A ASN 80 -140.07 21.89 5 A CYS 81 53.98 18.93 6 A ASP 48 -178.19 -99.89 6 A GLN 49 -130.43 -59.03 6 A CYS 50 -81.57 41.22 6 A SER 53 58.26 75.07 6 A GLN 64 -106.79 -165.07 6 A SER 67 -178.17 -132.90 6 A CYS 72 -56.97 -175.37 6 A GLU 77 -161.67 -36.14 6 A THR 83 -103.97 66.41 6 A HIS 84 -50.20 108.13 7 A ASP 46 -163.31 -40.16 7 A ASP 48 58.87 117.88 7 A SER 53 58.97 77.46 7 A SER 67 -165.44 -128.07 7 A GLU 77 -160.72 86.59 8 A GLN 49 45.67 -85.39 8 A SER 53 69.49 74.07 8 A SER 67 179.00 -136.12 8 A CYS 72 -60.19 -172.67 8 A GLU 77 -152.08 72.59 8 A ASN 80 -140.67 24.41 8 A HIS 84 -62.00 97.73 9 A ASP 46 178.98 68.87 9 A ASP 48 -94.00 -95.56 9 A GLN 49 -139.36 -61.52 9 A SER 52 -148.39 26.53 9 A SER 53 45.13 72.64 9 A SER 67 179.88 -118.24 9 A CYS 72 -70.77 -164.87 9 A ASN 80 -146.16 38.51 9 A CYS 81 43.27 26.62 10 A ASP 46 39.82 -161.98 10 A CYS 50 -84.52 47.01 10 A SER 52 -177.36 33.97 10 A ASN 57 39.93 61.00 10 A LEU 65 68.75 -82.81 10 A SER 67 -146.12 -139.00 10 A PHE 71 -140.03 -142.44 10 A CYS 72 -179.69 -157.69 10 A GLU 77 175.00 120.33 10 A HIS 84 -61.02 92.96 11 A ASP 48 -42.80 -93.27 11 A GLN 49 -132.57 -67.26 11 A SER 53 66.69 83.49 11 A CYS 55 -41.95 159.55 11 A SER 67 -177.91 -134.07 11 A PHE 71 -150.91 77.01 11 A CYS 72 -69.86 -152.84 11 A GLU 77 -178.75 137.69 11 A HIS 84 -43.62 105.52 12 A GLN 49 71.00 -27.77 12 A SER 53 67.44 71.20 12 A LEU 65 -59.93 -76.17 12 A GLN 66 -38.80 -39.17 12 A SER 67 -177.09 -115.33 12 A CYS 72 -79.47 -158.29 12 A GLU 77 -172.75 75.12 12 A ASN 80 -154.18 30.40 12 A THR 83 -109.14 59.20 13 A ASP 46 -137.10 -78.79 13 A GLN 49 71.78 -34.15 13 A SER 53 67.92 65.45 13 A CYS 55 -43.06 165.62 13 A GLN 64 -108.52 -155.31 13 A LEU 65 -56.18 -112.89 13 A GLN 66 -88.02 32.08 13 A PHE 71 -137.30 -34.67 13 A CYS 72 50.64 -157.29 13 A GLU 77 -174.98 148.16 13 A HIS 84 -45.92 107.07 14 A ASP 46 177.04 -89.06 14 A CYS 50 -84.06 40.35 14 A SER 53 66.10 80.24 14 A SER 67 -165.27 -132.09 14 A CYS 72 -76.42 -152.46 14 A GLU 77 -171.27 89.53 14 A ASN 80 -154.01 29.42 14 A THR 83 -106.60 57.78 15 A ASP 46 -45.32 171.23 15 A ASP 48 -88.28 -113.95 15 A GLN 49 -133.72 -62.25 15 A SER 52 -163.95 27.96 15 A SER 67 -179.15 -133.69 15 A CYS 72 -61.92 -178.32 15 A CYS 81 55.43 17.35 16 A ASP 48 58.63 117.49 16 A SER 53 66.04 90.21 16 A LEU 65 -43.33 -86.51 16 A GLN 66 -35.66 -30.33 16 A SER 67 170.60 -172.30 16 A CYS 72 -74.08 -160.76 16 A GLU 77 -171.11 107.27 16 A ASN 80 -153.36 30.29 16 A THR 83 -114.92 71.84 17 A ASP 46 178.21 114.71 17 A ASP 48 174.40 -28.99 17 A GLN 49 47.16 -84.44 17 A SER 52 -143.14 18.58 17 A SER 53 68.74 76.10 17 A LEU 65 -48.94 -79.63 17 A GLN 66 -36.39 -34.20 17 A SER 67 170.60 -154.00 17 A CYS 72 -56.43 -160.81 17 A GLU 77 -146.90 -42.83 18 A ASP 46 64.78 64.74 18 A ASP 48 171.23 -86.38 18 A GLN 49 -131.95 -60.47 18 A CYS 50 -83.39 42.21 18 A ALA 51 -100.08 -63.57 18 A SER 53 43.06 84.10 18 A LEU 65 -49.74 -86.42 18 A GLN 66 -36.00 -29.45 18 A SER 67 169.24 -155.89 18 A CYS 72 -56.48 -157.74 18 A GLU 77 -160.23 69.58 18 A THR 83 -105.21 58.70 19 A ASP 48 -144.68 -90.28 19 A GLN 49 -134.04 -50.00 19 A SER 53 66.71 75.47 19 A SER 67 179.66 -119.30 19 A CYS 72 -86.36 -156.35 19 A GLU 77 -137.65 -139.94 20 A ASP 46 61.64 86.00 20 A SER 53 68.64 66.77 20 A CYS 55 -42.28 157.17 20 A LEU 65 -51.72 -83.89 20 A GLN 66 -35.56 -30.35 20 A SER 67 169.50 -154.55 20 A CYS 72 -83.10 -153.18 20 A GLU 77 -170.35 132.32 20 A ASN 80 -153.98 26.17 20 A THR 83 -111.23 76.89 21 A ASP 46 -144.88 11.92 21 A SER 53 69.23 78.71 21 A GLN 64 -107.56 -163.53 21 A SER 67 -177.90 -123.25 21 A GLU 77 -170.87 85.20 21 A CYS 81 59.58 13.93 22 A ASP 48 164.50 124.43 22 A ALA 51 -93.92 -71.29 22 A SER 53 64.96 77.05 22 A LEU 65 68.10 -83.09 22 A SER 67 -144.57 -156.06 22 A CYS 72 -63.11 -170.89 22 A GLU 77 -171.75 63.15 22 A CYS 81 52.34 19.61 23 A CYS 50 -83.99 44.54 23 A SER 53 56.79 77.65 23 A SER 67 178.79 -113.45 23 A CYS 72 -61.65 -159.92 23 A GLU 77 -158.67 20.77 23 A CYS 81 58.93 15.04 23 A HIS 84 -48.40 105.33 model building X-PLOR 3.1 refinement X-PLOR 3.1 phasing X-PLOR 3.1 FACTOR VII N-TERMINAL EGF-LIKE DOMAIN FROM HUMAN FACTOR VII, NMR, 23 STRUCTURES 1 Y N A ASP 48 A ASP 4 HELX_P A SER 52 A SER 8 5 1 5 disulf 2.020 A CYS 50 A SG CYS 6 1_555 A CYS 61 A SG CYS 17 1_555 disulf 2.019 A CYS 55 A SG CYS 11 1_555 A CYS 70 A SG CYS 26 1_555 disulf 2.019 A CYS 72 A SG CYS 28 1_555 A CYS 81 A SG CYS 37 1_555 BLOOD COAGULATION BLOOD COAGULATION, EGF, HYDROLASE, SERINE PROTEASE FA7_HUMAN UNP 1 1 P08709 MVSQALRLLCLLLGLQGCLAAGGVAKASGGETRDMPWKPGPHRVFVTQEEAHGVLHRRRRANAFLEELRPGSLERECKEE QCSFEEAREIFKDAERTKLFWISYSDGDQCASSPCQNGGSCKDQLQSYICFCLPAFEGRNCETHKDDQLICVNENGGCEQ YCSDHTGTKRSCRCHEGYSLLADGVSCTPTVEYPCGKIPILEKRNASKPQGRIVGGKVCPKGECPWQVLLLVNGAQLCGG TLINTIWVVSAAHCFDKIKNWRNLIAVLGEHDLSEHDGDEQSRRVAQVIIPSTYVPGTTNHDIALLRLHQPVVLTDHVVP LCLPERTFSERTLAFVRFSLVSGWGQLLDRGATALELMVLNVPRLMTQDCLQQSRKVGDSPNITEYMFCAGYSDGSKDSC KGDSGGPHATHYRGTWYLTGIVSWGQGCATVGHFGVYTRVSQYIEWLQKLMRSEPRPGVLLRAPFP 105 145 1BF9 45 85 P08709 A 1 1 41 2 2 anti-parallel anti-parallel A SER 60 A SER 16 A ASP 63 A ASP 19 A TYR 68 A TYR 24 A PHE 71 A PHE 27 A PHE 76 A PHE 32 A GLU 77 A GLU 33 A THR 83 A THR 39 A HIS 84 A HIS 40 1 P 1